NDC 17478-604-01 - COSOPT PF
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17478-604
- Requested NDC
- 17478-604-01
- Package NDCs from labels
- 17478-604-01, 17478-604-90, 17478-604-30, 17478-604-00, 17478-604-15
- Manufacturer
- Akorn | Akorn Operating Company LLC
- Effective date
- 2020-10-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| COSOPT PF - Akorn | Akorn Operating Company LLC | Akorn | Akorn Operating Company LLC | 2020-10-08 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17478-604-00 | COSOPT PF | 15 in 1 POUCH | SOLUTION/ DROPS | 15 | 6 | |
| 17478-604-00 | COSOPT PF | 0.2 mL in 1 VIAL, SINGLE-USE | SOLUTION/ DROPS | 0.2 | 6 | |
| 17478-604-01 | COSOPT PF | 15 in 1 POUCH | SOLUTION/ DROPS | 15 | 6 | |
| 17478-604-01 | COSOPT PF | 0.2 mL in 1 VIAL, SINGLE-USE | SOLUTION/ DROPS | 0.2 | 6 | |
| 17478-604-15 | COSOPT PF | 2 in 1 CARTON | SOLUTION/ DROPS | 2 | 6 | |
| 17478-604-30 | COSOPT PF | 4 in 1 CARTON | SOLUTION/ DROPS | 4 | 6 | |
| 17478-604-90 | COSOPT PF | 12 in 1 CARTON | SOLUTION/ DROPS | 12 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17478-604-01 | EA - Each | 17478-604 | 376fd337-dfb7-4393-b398-a1bfaeb74662 | 1 | 2016-03-04 |
| 17478-604-30 | EA - Each | 17478-604 | 11a2fdb5-20d9-4501-be22-e70ab63f0691 | 1 | 2014-08-01 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Timolol Maleate | TIMOLOL MALEATE OPHTHALMIC | Micro Labs Limited | 6c9f3971-8c07-4d3a-915d-76438baa2a0b | 2024-10-03 | Warnings, Adverse reactions | P8Y54F701R |
| Dorzolamide Hydrochloride and Timolol Maleate ophthalmic Solution | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | Micro Labs Limited | f45cce05-fb47-4607-b68e-5a3d47e7235a | 2024-09-26 | Warnings, Adverse reactions | QZO5366EW7 P8Y54F701R |
| DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | Somerset Therapeutics, LLC | 17f04726-725f-4839-911d-47fc5e02baae | 2024-09-18 | Warnings, Adverse reactions | QZO5366EW7 P8Y54F701R |
| Dorzolamide Hydrochloride | DORZOLAMIDE HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 5ad43fd4-19f0-448f-97a8-625ada4cb147 | 2024-08-27 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride | DORZOLAMIDE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | fb2e0729-b0bc-4c3f-9961-8bb38f84a032 | 2024-08-27 | Warnings, Adverse reactions | QZO5366EW7 |
| DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE PRESERVATIVE FREE | Bryant Ranch Prepack | cfdc5577-fe7a-4b51-b2f5-95806e1dee2d | 2024-08-20 | Warnings, Adverse reactions | 1922783 QZO5366EW7 P8Y54F701R |
| Timolol Maleate | TIMOLOL MALEATE | Caplin Steriles Limited | 4847f180-45e6-40f0-ae8c-6cc500cb0add | 2024-08-19 | Warnings, Adverse reactions | P8Y54F701R |
| Empathy | AETHUSA CYNAPIUM, AMBRA GRISEA, ARGEMONE MEXICANA, CANDIDA ALBICANS, CARLSBAD AQUA, CEREBRUM SUIS, COCCULUS INDICUS, COFFEA TOSTA, CROCUS SATIVUS, CYCLAMEN EUROPAEUM, MAGNESIA CARBONICA, NATRUM CARBONICUM, NUPHAR LUTEUM, NUX MOSCHATA, PHOSPHORUS, PLACENTA TOTALIS SUIS, ROSA DAMASCENA, SUCCINUM, VIOLA ODORATA | Deseret Biologicals, Inc. | a89067c1-ef12-49da-8fa6-e65ff664f497 | 2024-08-13 | Warnings | 059QF0KO0R |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | American Health Packaging | 58fa9952-c8ab-4ebb-a073-15cc45f4832a | 2024-07-16 | Adverse reactions | 1Q73Q2JULR |
| Thompson Safety Eyewash | WATER | Thompson Safety | 1d0e96cf-245b-cfb7-e063-6294a90a4ced | 2024-07-12 | Warnings | 059QF0KO0R |
| Timolol hemihydrate | TIMOLOL HEMIHYDRATE | Somerset Therapeutics, LLC | bfd95433-e47a-4c5c-9bdf-77bffc13544d | 2024-07-10 | Warnings, Adverse reactions | P8Y54F701R |
| Timolol maleate | TIMOLOL MALEATE | Somerset Therapeutics, LLC | 5d60db57-ca24-4cab-a90d-8cf06992a34e | 2024-07-04 | Warnings, Adverse reactions | P8Y54F701R |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Honeywell Safety Products USA, Inc. | ad42a7e3-84ea-390d-e053-2a95a90a3a32 | 2024-06-14 | Warnings | 059QF0KO0R |
| Timolol Maleate | TIMOLOL MALEATE | Rising Pharma Holdings, Inc. | 0bc40b2c-65eb-4095-87e6-4752d5b19a3a | 2024-06-11 | Warnings, Adverse reactions | P8Y54F701R |
| Eyes Alive Eye Wash | WATER | RIVIERA PHARMA INC | 081079f4-1c06-4054-b771-00fedaa666f6 | 2024-06-05 | Warnings | 059QF0KO0R |
| TIMOLOL MALEATE | TIMOLOL MALEATE | A-S Medication Solutions | 1ffd9ed1-8ab4-4036-bbc6-dcf58e659248 | 2024-06-03 | Warnings, Adverse reactions | P8Y54F701R |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Chartwell RX, LLC | 525136c9-7758-437b-b57b-94b905786825 | 2024-05-31 | Adverse reactions | 1Q73Q2JULR |
| Sterile Water | WATER | Becton Dickinson and Company | 6e43c5a3-dad2-49ed-b500-964cb4563cc9 | 2024-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Timolol GFS | TIMOLOL MALEATE | Sandoz Inc | 72b0d0ec-832a-4c25-b845-2537ab506354 | 2024-05-28 | Warnings, Adverse reactions | P8Y54F701R |
| Dorzolamide and Timolol | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION | Leading Pharma, LLC | c9ae08c5-275d-44b3-9d1e-5d8fedc21b96 | 2024-05-25 | Warnings, Adverse reactions | QZO5366EW7 P8Y54F701R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.